InsiderTrades

Form 4 for NBIX NEUROCRINE BIOSCIENCES INC

Accepted 2024-07-18 00:00:00 ET · period of report 2024-07-16 · accession 0000914475-24-000176 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-07-18 2024-07-16 NBIX Cooke Julie CHRO M - OptEx $61.82 +900 19.1K +5% +$55.6K
D 2024-07-18 2024-07-16 NBIX Cooke Julie CHRO S - Sale+OE $150.04 -900 18.2K -5% -$135.0K
D 2024-07-18 2024-07-16 NBIX Cooke Julie CHRO M - OptEx $0.00 -900 12.6K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-07-16 M A 900 $61.82 19,102 D — —
2 Common Common Stock 2024-07-16 S D 900 $150.04 18,202 D — — (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.18. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. (F3) 16,538 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power
3 Derivative Non-Qualified Stock Option 2024-07-16 M D 900 $0.00 12,632 D $61.82 · — to 2027-10-02 900 Common Stock (F4) Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on October 2, 2018 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.